Apollo Medical Holdings, Inc. (AMEH) Tops Q2 EPS by 3c, beats revenue, offers guidance

Apollo Medical Holdings, Inc. (NASDAQ: AMEH) reported Q2 EPS of $0.28, $0.03 better than the analyst estimate of $0.25. Revenue for the quarter came in at $348.2 million versus the consensus estimate of $341.97 million.

GUIDANCE:

Apollo Medical Holdings, Inc. sees FY2023 EPS of $0.95-$1.20. Apollo Medical Holdings, Inc. sees FY2023 revenue of $1300-1500 million.

For earnings history and earnings-related data on Apollo Medical Holdings, Inc. (AMEH) click here.

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• Moody’s upgrades Brinker to Ba1 on Chili’s growth and debt reduction
• Moody’s upgrades Cushman & Wakefield rating to Ba3 on debt reduction